Mid-level Priming by Completion vs. Mosaic Solutions.
Ontology highlight
ABSTRACT:
SUBMITTER: Peta A
PROVIDER: S-EPMC6492368 | biostudies-other | 2019 Mar-Apr
REPOSITORIES: biostudies-other
Publications
Mid-level Priming by Completion vs. Mosaic Solutions.
Peta Antonio A Fantoni Carlo C Gerbino Walter W
i-Perception 20190301 2
We report two experiments on the role of mid-level processes in image segmentation and completion. In the primed matching task of Experiment 1, a cue→prime sequence was presented before the imperative stimulus consisting of target shapes with positive versus negative contour curvature polarity and one versus two axes of mirror symmetry. Priming shapes were included in two composite occlusion displays with the same T-junction information and different geometric features supporting a distinct bala ...[more]
Similar Datasets
Project description:As of March 30 2021, over 5,193 COVID-19 clinical trials have been registered through Clinicaltrial.gov. Among them, 191 trials were terminated, suspended, or withdrawn (indicating the cessation of the study). On the other hand, 909 trials have been completed (indicating the completion of the study). In this study, we propose to study underlying factors of COVID-19 trial completion vs. cessation, and design predictive models to accurately predict whether a COVID-19 trial may complete or cease in the future. We collect 4,441 COVID-19 trials from ClinicalTrial.gov to build a testbed, and design four types of features to characterize clinical trial administration, eligibility, study information, criteria, drug types, study keywords, as well as embedding features commonly used in the state-of-the-art machine learning. Our study shows that drug features and study keywords are most informative features, but all four types of features are essential for accurate trial prediction. By using predictive models, our approach achieves more than 0.87 AUC (Area Under the Curve) score and 0.81 balanced accuracy to correctly predict COVID-19 clinical trial completion vs. cessation. Our research shows that computational methods can deliver effective features to understand difference between completed vs. ceased COVID-19 trials. In addition, such models can also predict COVID-19 trial status with satisfactory accuracy, and help stakeholders better plan trials and minimize costs.
| S-EPMC8274906 | biostudies-literature
Project description:It is clear that early visual processing provides an image-based representation of the visual scene: Neurons in Striate cortex (V1) encode nothing about the meaning of a scene, but they do provide a great deal of information about the image features within it. The mechanisms of these "low-level" visual processes are relatively well understood. We can construct plausible models for how neurons, up to and including those in V1, build their representations from preceding inputs down to the level of photoreceptors. It is also clear that at some point we have a semantic, "high-level" representation of the visual scene because we can describe verbally the objects that we are viewing and their meaning to us. A huge number of studies are examining these "high-level" visual processes each year. Less well studied are the processes of "mid-level" vision, which presumably provide the bridge between these "low-level" representations of edges, colors, and lights and the "high-level" semantic representations of objects, faces, and scenes. This article and the special issue of papers in which it is published consider the nature of "mid-level" visual processing and some of the reasons why we might not have made as much progress in this domain as we would like.
| S-EPMC4461896 | biostudies-other
Project description:BACKGROUND:Oral rehydration solution (ORS) is used to treat the dehydration caused by diarrhoeal diseases, including cholera. ORS formulations with an osmolarity (a measure of solute concentration) of ? 270 mOsm/L (ORS ? 270) are safe and more effective than ORS formulations with an osmolarity of ? 310 mOsm/L (ORS ? 310) for treating non-cholera diarrhoea. As cholera causes rapid electrolyte loss, it is important to know if these benefits are similar for people suffering from cholera. OBJECTIVES:To compare the safety and efficacy of ORS ?270 with ORS ? 310 for treating dehydration due to cholera. SEARCH METHODS:We searched the Cochrane Infectious Disease Group Specialized Register (April 2011), CENTRAL (The Cochrane Library Issue 4, 2011), MEDLINE (1966 to April 2011), EMBASE (1974 to April 2011), and LILACS (1982 to April 2011). We also contacted organizations and searched reference lists. SELECTION CRITERIA:Randomized controlled trials comparing ORS ? 270 with ORS ? 310 for treating adults and children with acute diarrhoea due to cholera. DATA COLLECTION AND ANALYSIS:Two reviewers independently applied eligibility criteria, assessed trial quality, and extracted data. We pooled dichotomous data using risk ratio (RR), pooled continuous data using mean difference (MD) or the standardized mean difference (SMD), and presented the results with 95% confidence intervals (CI). MAIN RESULTS:For glucose-based ORS, seven trials (718 participants) met the inclusion criteria. Biochemical hyponatraemia (blood sodium levels < 130 mmol/L) was more common with ORS ? 270 (RR 1.67, CI 1.09 to 2.57; 465 participants, four trials), while a higher level of severe biochemical hyponatraemia (blood sodium levels < 125 mmol/L) in the same group was not significant (RR 1.58, CI 0.62 to 4.04; 465 participants, four trials). No instances of symptomatic hyponatraemia or death were noted in the trials that intended to record them. We found no statistically significant difference in the need for unscheduled intravenous infusion. Analyses separating children and adults showed no obvious trends.Two trials also examined rice-based ORS. In the ORS ? 270 group, duration of diarrhoea was shorter (MD -11.42 hours, CI -13.80 to -9.04; 102 participants, two trials). AUTHORS' CONCLUSIONS:In people with cholera, ORS ? 270 is associated with biochemical hyponatraemia when compared with ORS ? 310, but there are no differences in terms of other outcomes. Although this risk does not appear to be associated with any serious consequences, the total patient experience in existing trials is small. Under wider practice conditions, especially where patient monitoring is difficult, caution is warranted.
| S-EPMC6532622 | biostudies-literature
Project description:Semantic priming is usually studied by examining ERPs over many trials and subjects. This article aims at detecting semantic priming at the single-trial level. By using machine learning techniques it is possible to analyse and classify short traces of brain activity, which could, for example, be used to build a Brain Computer Interface (BCI). This article describes an experiment where subjects were presented with word pairs and asked to decide whether the words were related or not. A classifier was trained to determine whether the subjects judged words as related or unrelated based on one second of EEG data. The results show that the classifier accuracy when training per subject varies between 54% and 67%, and is significantly above chance level for all subjects (N ?=?12) and the accuracy when training over subjects varies between 51% and 63%, and is significantly above chance level for 11 subjects, pointing to a general effect.
| S-EPMC3615017 | biostudies-literature
Project description:Cancer immunotherapy approaches have emerged as novel treatment regimens against cancer. A particularly interesting avenue is the concept of in situ vaccination, where immunostimulatory agents are introduced into an identified tumor to overcome local immunosuppression and, if successful, mount systemic antitumor immunity. We had previously shown that nanoparticles from cowpea mosaic virus (CPMV) are highly potent in inducing long-lasting antitumor immunity when used as an in situ vaccine in various tumor mouse models. Here we asked whether the nanoparticles from tobacco mosaic virus (TMV) could also be applied as an in situ vaccine and, if so, whether efficacy or mechanism of immune-activation would be affected by the nanoparticle size (300 × 18 nm native TMV vs 50 × 18 nm short TMV nanorods), shape (nanorods vs spherical TMV, termed SNP), or state of assembly (assembled TMV rod vs free coat protein, CP). Our studies indicate that CPMV, but less so TMV, elicits potent antitumor immunity after intratumoral treatment of dermal melanoma (B16F10 using C57BL/6 mice). TMV and TMVshort slowed tumor growth and increased survival time, however, at significantly lower potency compared to that of CPMV. There were no apparent differences between TMV, TMVshort, or the SNP indicating that the aspect ratio does not necessarily play a role in plant viral in situ vaccines. The free CPs did not elicit an antitumor response or immunostimulation, which may indicate that a multivalent assembly is required to trigger an innate immune recognition and activation. Differential potency of CPMV vs TMV can be explained with differences in immune-activation: data indicate that CPMV stimulates an antitumor response through recruitment of monocytes into the tumor microenvironment (TME), establishing signaling through the IFN-? pathway, which also leads to recruitment of tumor-infiltrated neutrophils (TINs) and natural killer (NK) cells. Furthermore, the priming of the innate immune system also mounts an adaptive response with CD4+ and CD8+ T cell recruitment and establishment of effector memory cells. While the TMV treatment also lead to the recruitment of innate immune cells as well as T cells (although to a lesser degree), key differences were noted in cyto/chemokine profiling with TMV inducing a potent immune response early on characterized by strong pro-inflammatory cytokines, primarily IL-6. Together, data indicate that some plant viral nanotechnology platforms are more suitable for application as in situ vaccines than others; understanding the intricate differences and underlying mechanism of immune-activation may set the stage for clinical development of these technologies.
| S-EPMC6230260 | biostudies-literature
Project description:Human object-selective cortex shows a large-scale organization characterized by the high-level properties of both animacy and object size. To what extent are these neural responses explained by primitive perceptual features that distinguish animals from objects and big objects from small objects? To address this question, we used a texture synthesis algorithm to create a class of stimuli-texforms-which preserve some mid-level texture and form information from objects while rendering them unrecognizable. We found that unrecognizable texforms were sufficient to elicit the large-scale organizations of object-selective cortex along the entire ventral pathway. Further, the structure in the neural patterns elicited by texforms was well predicted by curvature features and by intermediate layers of a deep convolutional neural network, supporting the mid-level nature of the representations. These results provide clear evidence that a substantial portion of ventral stream organization can be accounted for by coarse texture and form information without requiring explicit recognition of intact objects.
| S-EPMC6156638 | biostudies-literature
Project description:Mid-frequency Raman difference spectra (MFRDS) analysis can be used to reveal the selective crystallization from solutions through determining the degree of similarity of the short-range orders between the assemblies of small organic molecules in solutions and their solid phases. Four solid phases of inosine (IR) (α-anhydrous IR (α-IR), β-anhydrous IR (β-IR), IR dihydrate (IRD), and amorphous IR (AmIR)) and two IR solutions (aqueous and 70 vol% DMSO aqueous solution) were prepared and characterized using MFRDS here. The MFRDS analysis results indicate that the selective formation of IRD and AmIR from IR aqueous solution and β-IR from IR 70 vol% DMSO solution are originated from the high similarity of their short-range structures. Moreover, we propose that the formation of α-IR from IR aqueous solution benefits from the appearance of AmIR as an intermediate phase. MFRDS is a robust tool to explain and predict the possible precipitation products from various solutions of small organic molecules.
| S-EPMC9215128 | biostudies-literature
Project description:Systemic acquired resistance (SAR) is a broad-spectrum disease resistance response that can be induced upon infection from pathogens or by chemical treatment, such as with benzo-(1,2,3)-thiadiazole-7-carbothioic acid S-methyl ester (BTH). SAR involves priming for more robust activation of defence genes upon pathogen attack. Whether priming for SAR would involve components of RNA silencing remained unknown. Here, we show that upon leaf infiltration of water, BTH-primed Arabidopsis thaliana plants accumulate higher amounts of mRNA of ARGONAUTE (AGO)2 and AGO3, key components of RNA silencing. The enhanced AGO2 expression is associated with prior-to-activation trimethylation of lysine 4 in histone H3 and acetylation of histone H3 in the AGO2 promoter and with induced resistance to the yellow strain of cucumber mosaic virus (CMV[Y]). The results suggest that priming A. thaliana for enhanced defence involves modification of histones in the AGO2 promoter that condition AGO2 for enhanced activation, associated with resistance to CMV(Y). Consistently, the fold-reduction in CMV(Y) coat protein accumulation by BTH pretreatment was lower in ago2 than in wild type, pointing to reduced capacity of ago2 to activate BTH-induced CMV(Y) resistance. A role of AGO2 in pathogen-induced SAR is suggested by the enhanced activation of AGO2 after infiltrating systemic leaves of plants expressing a localized hypersensitive response upon CMV(Y) infection. In addition, local inoculation of SAR-inducing Pseudomonas syringae pv. maculicola causes systemic priming for enhanced AGO2 expression. Together our results indicate that defence priming targets the AGO2 component of RNA silencing whose enhanced expression is likely to contribute to SAR.
| S-EPMC7749747 | biostudies-literature
Project description:OBJECTIVE:Understanding pedestrian injury trends at the local level is essential for program planning and allocation of funds for urban planning and improvement. Because we hypothesize that local injury trends differ from national trends in significant and meaningful ways, we investigated citywide pedestrian injury trends to assess injury risk among nationally identified risk groups, as well as identify risk groups and locations specific to Baltimore City. METHODS:Pedestrian injury data, obtained from the Baltimore City Fire Department, were gathered through emergency medical services (EMS) records collected from January 1 to December 31, 2014. Locations of pedestrian injuries were geocoded and mapped. Pearson's chi-square test of independence was used to investigate differences in injury severity level across risk groups. Pedestrian injury rates by age group, gender, and race were compared to national rates. RESULTS:A total of 699 pedestrians were involved in motor vehicle crashes in 2014-an average of 2 EMS transports each day. The distribution of injuries throughout the city did not coincide with population or income distributions, indicating that there was not a consistent correlation between areas of concentrated population or concentrated poverty and areas of concentrated pedestrian injury. Twenty percent (n = 138) of all injuries occurred among children age ?14, and 22% (n = 73) of severe injuries occurred among young children. The rate of injury in this age group was 5 times the national rate (Incident Rate Ratio [IRR] = 4.81, 95% confidence interval [CI], [4.05, 5.71]). Injury rates for adults ?65 were less than the national average. CONCLUSIONS:As the urban landscape and associated pedestrian behavior transform, continued investigation of local pedestrian injury trends and evolving public health prevention strategies is necessary to ensure pedestrian safety.
| S-EPMC5918155 | biostudies-literature
Project description:AbstractNishioka, T and Okada, J. Influence of strength level on performance enhancement using resistance priming. J Strength Cond Res 36(1): 37-46, 2022-The current study aimed to investigate (a) whether resistance priming was effective in enhancing jump performance for both stronger and weaker individuals and (b) how resistance priming influences the lower-body force-velocity profile. A total of 20 resistance-trained men performed priming and control conditions 72-144 hours apart in a randomized and counterbalanced order. Jump performances (0 and 40% 1 repetition maximum [1RM] squat jump, 0 and 40% 1RM countermovement jump [CMJ] and drop jump) were assessed before and 24 hours after the priming session, and before and 24 hours after rest (control). Priming session-induced percentage change in 0% 1RM CMJ height was positively correlated with the individual's relative half squat 1RM (r = 0.612, p ≤ 0.05). Using the median split method, subjects were divided into stronger (relative half squat 1RM = 1.93-2.67 kg·kg-1) and weaker (relative half squat 1RM = 1.37-1.92 kg·kg-1) groups and subsequently analyzed. The stronger group showed specific improvement in 0% 1RM CMJ performance 24 hours after the priming session (p ≤ 0.05), whereas the weaker group showed no improvement in any of their jump performances. Moreover, the priming session enhanced the theoretical maximum velocity (p ≤ 0.05), but not the theoretical maximum force during CMJ in the stronger group; whereas none of the force-velocity profile variables were enhanced in the weaker group. These results suggest that stronger individuals are more likely to experience performance enhancement using resistance priming, which may be movement- and velocity-specific.
| S-EPMC8677605 | biostudies-literature